Issues

Regeneron (NASDAQ: REGN) has stopped enrolling seriously ill Covid-19 patients in a clinical trial of its antibody treatment. This is the antibody “cocktail” President Trump received during his treatment… Read more

In 2016 all of the major polls predicted that Hillary Clinton would WIN. Yet the Presidential Predictor disagreed. And it accurately predicted that Republican Donald Trump would WIN the… Read more

Yesterday was “Super Thursday” for technology stocks as many of the world’s largest companies reported results. As our economy shows tentative signs of improvement, Amazon, Apple, Alphabet and Facebook… Read more

Coronavirus has likely become the leading cause of death among young people in some regions of the U.S., says a new study. It’s another big hole blown into the… Read more

There is another promising line of attack against the coronavirus. . .T-cells. This new line of attack was revealed in a new study published in Blood. T-cells taken from… Read more

Airbnb filed for a CONFIDENTIAL IPO in August. And today we’re getting more details on the secret Airbnb IPO plans. Go here to discover how to BUY Pre-IPO shares… Read more

It’s going to be the biggest IPO ever . . . with an expected valuation of $315 billion! The company is called Ant Group (private). And shares are expected… Read more

Natural immunity (high antibody levels) may not last more than a few months, a study from England suggests. It’s just the latest study to report such findings. That means… Read more

“TikTok parent ByteDance in early IPO talks to list businesses including short video app Douyin.” That’s according to reports from CNBC and Reuters. Go here to discover how to… Read more